ロード中...
Extension of the life span of pressure ulcer fibroblasts with recombinant human interleukin-1 beta.
Recombinant human interleukin-1 beta (rhuIL-1 beta) was investigated in a randomized, blinded placebo-controlled trial to evaluate its effect on the healing of chronic pressure ulcers. The influence of this topically applied cytokine to 26 pressure ulcer patients was correlated with tissue culture a...
保存先:
| 主要な著者: | , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
1995
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1869276/ https://ncbi.nlm.nih.gov/pubmed/7747819 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|